Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Kyverna Therapeutics has appointed Greg Martini as its new Chief Financial Officer effective May 18, 2026. Martini brings extensive financial leadership experience from his prior role as CFO at Ironwood Pharmaceuticals and will oversee financial operations as Kyverna advances its lead CAR T-cell therapy candidate, miv-cel, towards potential regulat…
StepStone Group Inc. has appointed Taylor Benson as the Head of U.S. Defined Contribution to lead the firm's new initiative focused on integrating diversified private markets exposure into retirement portfolios. This move targets growing demand from retirement plan sponsors and fiduciaries for private market solutions aligned with fiduciary governa…
Aeries Technology, a NASDAQ-listed company specializing in AI-driven business transformation for private equity portfolio companies, has introduced its new platform, A1 GCC. This AI-powered operations platform is designed to enhance the management of Global Capability Centers (GCC) by integrating planning, workforce management, governance, coordina…
Protara Therapeutics is hosting a virtual investor webinar to present an overview of lymphatic malformations (LMs), the current treatment landscape, regulatory designations, and clinical data supporting their investigational cell therapy TARA-002. The therapy has received several FDA designations including Rare Pediatric Disease and Breakthrough Th…
National Healthcare Properties, a healthcare-focused real estate investment trust, announced concurrent tender offers to repurchase up to $100 million aggregate purchase price of its 7.375% Series A and 7.125% Series B cumulative redeemable perpetual preferred stock at $22.50 per share. The offers commence May 18, 2026, expire June 16, 2026, and wi…
Enphase Energy has introduced its PowerMatch technology for IQ Battery 10C and 5P systems in the United States, Puerto Rico, Canada, Mexico, and select countries in Central America and the Caribbean. PowerMatch intelligently adjusts battery inverter operation in real-time to match home power usage, reducing energy losses and increasing efficiency. …
CareCloud, Inc. has fully redeemed its outstanding 8.75% Series B Preferred Stock using proceeds from a newly secured $50 million credit facility. This milestone marks the company's transition to a cleaner, more efficient capital structure, facilitating stronger cash flow and continued growth in its AI-powered healthcare technology platform. The co…
CPI Aerostructures, Inc. (NYSE American: CVU) announced robust first quarter 2026 financial results highlighting a 13% revenue increase to $17.4 million and a notable turnaround to $1.2 million net income compared to a net loss in Q1 2025. Gross profit margin expanded significantly due to a favorable product mix and operational efficiencies. Adjust…
CytomX Therapeutics announced the appointment of Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs to lead global regulatory strategy and support the advancement of its PROBODY® pipeline, including the lead program Varseta-M towards potential approval and commercialization. Dr. Gokhale brings over 25 years of experience in …
Black Rock Coffee Bar announced that Cynosure acquired shares pledged by the founders to pay off their margin loan fully. Cynosure now holds approximately 13.6 million shares and intends to deepen its partnership with the company. Founders remain active shareholders and board members. The transaction underscores confidence in Black Rock Coffee Bar'…
Digital Realty has opened its first data center in Barcelona, known as BCN1, marking a strategic expansion in the Mediterranean region. Designed to support next-generation technologies such as AI and cloud computing, BCN1 enhances connectivity between key global areas and complements the firm's existing facilities on the Iberian Peninsula. Built wi…
Krystal Biotech, Inc. announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved VYJUVEK® (beremagene geperpavec-svdt) for treating wounds in dystrophic epidermolysis bullosa (DEB) patients from birth with COL7A1 gene mutations. This marks the first genetic medicine approval in the UK for DEB, complementing prior …
Outdoor Holding Company, owner of GunBroker.com and ammunition producer, announced a cash dividend of $0.546875 per share on its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock to be paid on June 15, 2026 to holders of record as of June 1, 2026.
Catheter Precision, Inc., a U.S.-based medical device company, announced a 200% revenue increase in Q1 2026 driven by strong growth in its electrophysiology products and the recently acquired aviation platform Flyte. The acquisition has enabled rapid scaling of Flyte's fleet and immediate revenue contribution, while the medical device segment conti…
Garrett Motion Inc. announced a successful repricing of its $635 million term loan due 2032, lowering the interest rate by 25 basis points to SOFR plus 175 basis points. The company also made an early repayment of $50 million to reduce debt, reflecting lender confidence and expected improvements in financial strength and liquidity.
Rein Therapeutics, a clinical-stage biotech focused on orphan pulmonary and fibrosis diseases, has closed an underwritten public offering raising $57.5 million. Proceeds will fully fund the ongoing Phase 2 trial of LTI-03 in idiopathic pulmonary fibrosis (IPF), support ongoing clinical and regulatory activities, and extend operational cash runway i…
Alignment Healthcare, a Medicare Advantage health services company focused on senior care, announced it will present at the prestigious Goldman Sachs Healthcare Conference, highlighting its growth and strategic initiatives in senior healthcare delivery.
Reviva Pharmaceuticals Holdings, a late-stage biopharmaceutical company focused on CNS, inflammatory, and cardiometabolic diseases, announced that its CEO, Laxminarayan Bhat, PhD, will participate in a fireside chat at A.G.P.'s Annual Healthcare Company Showcase. The company highlighted its pipeline, including two drug candidates, brilaroxazine and…
SpyGlass Pharma announced that the AMA CPT Editorial Panel has approved a new add-on Category III CPT code for their BIM-IOL System, a drug-eluting intraocular lens implant designed to treat glaucoma and cataracts in a single surgery. This reimbursement code supports utilization tracking and future coverage, helping pave the way for product commerc…
Enlivex Ltd. has dosed the first patient in the United States as part of its global Phase 2b clinical trial evaluating Allocetra for treating moderate-to-severe age-related primary knee osteoarthritis. Following FDA IND clearance and Danish regulatory approval, the trial will assess efficacy and safety across multiple countries, targeting an unmet …
Silicon Motion Technology Corporation, a leading supplier of NAND flash controllers worldwide, announced its participation in several prestigious investor conferences throughout May and June 2026, including J.P. Morgan, B. Riley Securities, Morgan Stanley Asia AI Summit, Evercore Global TMT Conference, Citi Taiwan Tech Conference, and Bank of Ameri…
LGI Homes, Inc. has opened Cypress Trails, a premier master-planned community in Hockley near Cypress, Texas. This development features over 500 homes with a range of layouts and price points starting from the mid-$200,000s, complemented by resort-style amenities such as parks, pickleball courts, and walking trails. Positioned strategically with ea…
Enhanced Group announced a strategic multi-million dollar partnership with Rezolve Ai to utilize AI-powered technologies for its Live Enhanced consumer platform and the inaugural Enhanced Games. The collaboration will start with a mobile-first AI-enabled web experience for event attendees, featuring ticketing, athlete information, and real-time eng…
Alaunos Therapeutics announced updated preclinical results for ALN1003, their oral metabolic therapeutic candidate, demonstrating positive effects on insulin-resistance-related biomarkers, adipose tissue endocrine markers, and liver histology in diet-induced obesity mouse models. These findings support continued preclinical development for metaboli…
Nvidia will report first-quarter results after the close on Wednesday. Morgan Stanley analyst Joseph Moore expects a continued beat-and-raise cadence, boosting near-term revenue and earnings forecasts and raising longer-term targets tied to the company’s AI architectures and datacenter demand. Key areas to watch include guidance, margins amid a Rub…
